Annual ROA
-6.87%
+19.16%+73.61%
31 December 2023
Summary:
CRISPR Therapeutics AG annual return on assets is currently -6.87%, with the most recent change of +19.16% (+73.61%) on 31 December 2023. During the last 3 years, it has risen by +17.23% (+71.49%). CRSP annual ROA is now -141.66% below its all-time high of 16.49%, reached on 31 December 2021.CRSP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-10.34%
+1.35%+11.55%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly return on assets is currently -10.34%, with the most recent change of +1.35% (+11.55%) on 30 September 2024. Over the past year, it has increased by +5.55% (+34.93%). CRSP quarterly ROA is now -142.67% below its all-time high of 24.23%, reached on 30 June 2021.CRSP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +73.6% | +34.9% |
| 3 y3 years | +71.5% | -155.2% |
| 5 y5 years | +84.2% | -399.5% |
CRSP ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -141.7% | +73.6% | -155.2% | +60.5% |
| 5 y | 5 years | -141.7% | +84.2% | -142.7% | +61.9% |
| alltime | all time | -141.7% | +98.5% | -142.7% | +75.7% |
CRISPR Therapeutics AG ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -10.34%(-11.5%) |
| June 2024 | - | -11.69%(+20.5%) |
| Mar 2024 | - | -9.70%(+39.0%) |
| Dec 2023 | -6.87%(-73.6%) | -6.98%(-56.1%) |
| Sept 2023 | - | -15.89%(-12.1%) |
| June 2023 | - | -18.08%(-17.8%) |
| Mar 2023 | - | -22.00%(-16.0%) |
| Dec 2022 | -26.03%(-257.9%) | -26.18%(-0.0%) |
| Sept 2022 | - | -26.19%(+12.0%) |
| June 2022 | - | -23.39%(-295.7%) |
| Mar 2022 | - | 11.95%(-22.4%) |
| Dec 2021 | 16.49%(-168.4%) | 15.40%(-17.8%) |
| Sept 2021 | - | 18.73%(-22.7%) |
| June 2021 | - | 24.23%(-190.5%) |
| Mar 2021 | - | -26.78%(-1.2%) |
| Dec 2020 | -24.10% | -27.11%(+36.7%) |
| Sept 2020 | - | -19.83%(-977.4%) |
| June 2020 | - | 2.26%(-62.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | 6.01%(-41.3%) |
| Dec 2019 | 8.59%(-119.8%) | 10.23%(-594.2%) |
| Sept 2019 | - | -2.07%(-95.1%) |
| June 2019 | - | -42.58%(+2.8%) |
| Mar 2019 | - | -41.44%(+0.8%) |
| Dec 2018 | -43.40%(+95.7%) | -41.10%(+26.2%) |
| Sept 2018 | - | -32.57%(+13.2%) |
| June 2018 | - | -28.76%(+19.0%) |
| Mar 2018 | - | -24.17%(+7.9%) |
| Dec 2017 | -22.18%(+141.1%) | -22.40%(+33.7%) |
| Sept 2017 | - | -16.76%(+25.1%) |
| June 2017 | - | -13.40%(+14.5%) |
| Mar 2017 | - | -11.70%(+35.7%) |
| Dec 2016 | -9.20%(-43.2%) | -8.62%(-60.1%) |
| Sept 2016 | - | -21.58%(+10.3%) |
| June 2016 | - | -19.56%(+15.1%) |
| Mar 2016 | - | -16.99%(+45.3%) |
| Dec 2015 | -16.20%(-96.4%) | -11.69% |
| Dec 2014 | -445.32% | - |
FAQ
- What is CRISPR Therapeutics AG annual return on assets?
- What is the all time high annual ROA for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual ROA year-on-year change?
- What is CRISPR Therapeutics AG quarterly return on assets?
- What is the all time high quarterly ROA for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly ROA year-on-year change?
What is CRISPR Therapeutics AG annual return on assets?
The current annual ROA of CRSP is -6.87%
What is the all time high annual ROA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual return on assets is 16.49%
What is CRISPR Therapeutics AG annual ROA year-on-year change?
Over the past year, CRSP annual return on assets has changed by +19.16% (+73.61%)
What is CRISPR Therapeutics AG quarterly return on assets?
The current quarterly ROA of CRSP is -10.34%
What is the all time high quarterly ROA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly return on assets is 24.23%
What is CRISPR Therapeutics AG quarterly ROA year-on-year change?
Over the past year, CRSP quarterly return on assets has changed by +5.55% (+34.93%)